Louisiana State University Health Sciences Center in New Orleans

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Louisiana State University Health Sciences Center in New Orleans sits in the top decile of US sponsors by registered trial count (#397 of 15,742 sponsors by registered trial count).

45 total trials 7 currently recruiting 30 completed top decile by trial count

Louisiana State University Health Sciences Center in New Orleans: 45 sponsored US clinical trials, 7 recruiting.

Louisiana State University Health Sciences Center in New Orleans sponsors 45 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 30 completed. 8 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Health Adults, with 1 trials.

Top-decile sponsor footprint

Louisiana State University Health Sciences Center in New Orleans ranks in the top decile of sponsors by registered trial count (#397 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 74/100

30 of 32 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

45 total, page 1 of 1

RECRUITING Phase 4

Clinical Performance of Nobel N1 System

NCT07280260

RECRUITING NA

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

NCT07576595

RECRUITING NA

Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

NCT06773715

RECRUITING NA

Investigation Of Bioabsorbable Screws In Pediatric Orthopedic Surgery

NCT06429267

RECRUITING Phase 4

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

NCT05266898

RECRUITING Phase 4

Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?

NCT05663684

RECRUITING

New Orleans Pulmonary Hypertension Biobank

NCT03269630

ACTIVE NOT RECRUITING NA

Broccoli Extract Supplementation in Older Adults With Alcohol Use Disorder

NCT05902754

ACTIVE NOT RECRUITING

Anti-obesity Pharmacotherapy and Inflammation

NCT05756764

NOT YET RECRUITING NA

Periodontal Inflammation and Epigenetics in Obese Individuals

NCT07610902

NOT YET RECRUITING Phase 1

Precision Microbiota Interventions for Senoreduction Trial

NCT07462767

NOT YET RECRUITING NA

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

NCT07488156

COMPLETED Early Phase 1

Clinical Evaluation of no Needle Dental Anesthesia Compared to Syringe Anesthesia Delivery

NCT06874244

NOT YET RECRUITING NA

Optimal Injection Interval for Intra-Detrusor Botulinum Toxin

NCT06483217

COMPLETED Phase 4

Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study

NCT06342973

COMPLETED Phase 2

Tranexamic Acid for The Management of Bleeding Gastrointestinal Angioectasias

NCT07125508

COMPLETED NA

The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites

NCT06677333

COMPLETED NA

Assessing the Feasibility and Preliminary Impact of a mHealth App on Reducing STI Risk in Black MSM PrEP Users

NCT05395754

COMPLETED NA

Use of CBCT to Improve Inferior Alveolar Nerve Block Success

NCT05406895

TERMINATED Phase 4

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

NCT05120726

COMPLETED Phase 3

Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis

NCT04475081

COMPLETED NA

Community Resilience Learning Collaborative and Research Network

NCT03977844

COMPLETED NA

Power Training Combined With Interval Treadmill Training

NCT03625570

COMPLETED NA

Utilization of a Periodontal Endoscope in Nonsurgical Periodontal Therapy

NCT05293301

COMPLETED NA

Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions

NCT03299205

COMPLETED NA

Clinical Performance of Posterior Composite Tooth Fillings in Adults

NCT03175627

COMPLETED

Hypertension in Long-Term Care Facilities

NCT03046420

COMPLETED Phase 4

Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation

NCT03026777

COMPLETED NA

Survivors of Sex Trafficking: Occupation-Based Interventions for Executive Functioning

NCT03611998

COMPLETED NA

Clinical Performance of Posterior Glass Ionomer Restorations in Adolescents (KETAC)

NCT02705729

COMPLETED

Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary HTN (CRAB-PH)

NCT02873039

COMPLETED NA

SBI in Children With d-IBS

NCT02609529

COMPLETED

Understanding the Influence of Pregnancy on Breast Milk

NCT02317653

COMPLETED

Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension

NCT02331225

COMPLETED Phase 2

Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients

NCT01941225

COMPLETED NA

HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions

NCT03238586

TERMINATED Phase 2

Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II

NCT01451723

COMPLETED NA

Asthma and Obesity Diet Versus Exercise

NCT03644355

COMPLETED NA

Strength Training Induced Alterations in Markers of Immune Function

NCT01450852

COMPLETED Phase 1

Safety of Polyphenon E in Multiple Sclerosis Pilot Study

NCT00836719

COMPLETED Phase 2

Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors

NCT00590343

COMPLETED Phase 2

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

NCT00784849

COMPLETED NA

Lamotrigine Augmentation in Resistant Depression

NCT00901407

COMPLETED Phase 3

Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites

NCT01244997

COMPLETED NA

Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

NCT00002174

What is open in the Louisiana State University Health Sciences Center in New Orleans pipeline

7 recruiting of 45 indexed (16% open); 30 completed (67%).

Phase mix: 8 late (III/IV) vs 8 early (I/II) (balanced across stages).

Top condition: Health Adults (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Louisiana State University Health Sciences Center in New Orleans: open-pipeline peers nationwide

Peers matched on 45 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

Louisiana State University Health Sciences Center in New Orleans sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share Louisiana State University Health Sciences Center in New OrleansAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsAIDS Malignancy ConsortiumCambridge Health AllianceCarilion ClinicRoswell Park Cancer InstituteIncyte CorporationBrigham and Women's HospitalNorthwestern University
Louisiana State University Health Sciences Center in New Orleans sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Louisiana State University Health Sciences Center in New Orleans sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 45 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

What to do with this Louisiana State University Health Sciences Center in New Orleans page

45 registered trials is a research-attention snapshot, not an endorsement of Louisiana State University Health Sciences Center in New Orleans or any single study.

  • 7 of Louisiana State University Health Sciences Center in New Orleans's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Health Adults is the condition Louisiana State University Health Sciences Center in New Orleans studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Health Adults trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Louisiana State University Health Sciences Center in New Orleans pipeline card: 45 registered trials from official public datasets.Report a data error.